Canopy Growth’s stock falls back from recent gains as cannabis stocks cool off
September 12, 2023 at 13:26 PM EDT
The optimism around a potential rescheduling of cannabis fades as 14 Republican members of Congress say pot should remain a Schedule I drug under federal law.
